Dr. Manel Esteller Among the World's Top 500 Scientists According to the Research.com 2026 Ranking
Dr. Manel Esteller, head of the Cancer Epigenetics Research Group at the Institut de Recerca Sant Pau (IR Sant Pau), ranks 490th worldwide and fifth in Spain in Research.com's Best Scientists 2026 ranking, an international classification that recognizes researchers based on the impact of their scientific publications. This result places Dr. Esteller among the highest-ranked Spanish researchers in a classification that evaluates scientific output and its impact on the international research community.
Dr. Esteller is an internationally recognized leader in the field of cancer epigenetics, a discipline that studies the mechanisms regulating gene activity without altering the DNA sequence. Throughout his career, his research has contributed to understanding how epigenetic alterations are involved in the development and progression of tumors, as well as in the response to treatments. This knowledge opens up new opportunities to identify biomarkers, improve diagnosis, and develop more personalized therapeutic strategies.
In addition to leading the Cancer Epigenetics Research Group at IR Sant Pau, the researcher is an ICREA Research Professor and Professor of Genetics at the University of Barcelona. He joined IR Sant Pau in November 2025, where his scientific work focuses on studying the molecular mechanisms of cancer and identifying new opportunities to translate knowledge of epigenetics into clinical practice.
One of the research lines developed by his team addresses the role of epigenetic alterations in the progression of hematologic diseases. In this field, a study published in July 2026 in the scientific journal Leukemia analyzed the mechanisms involved in the progression of myelodysplastic syndromes to secondary acute myeloid leukemia, an aggressive form of blood cancer. By combining different molecular techniques to study individual malignant cells, the researchers identified the significant role of epigenetic alterations in disease progression. The findings contribute to expanding knowledge of the biological processes associated with tumor progression and resistance to treatment.
Research.com is an international platform specializing in the collection and analysis of information on researchers, universities, and scientific institutions. Its Best Scientists ranking is primarily based on the h-index, a bibliometric indicator that combines a researcher's scientific output with the citations received by their publications. To compile the ranking, the platform uses information from bibliographic databases such as OpenAlex and Crossref, along with discipline-specific selection criteria and scientific profile verification processes.
This system makes it possible to identify researchers with an extensive record of publications widely cited by the scientific community, although bibliometric indicators alone do not capture every dimension of research quality and impact. The ranking therefore provides a quantitative perspective on researchers' academic standing in their respective fields of knowledge.
Dr. Esteller's inclusion in the 2026 ranking highlights the international impact of his scientific career and the relevance of epigenetics as a field of study in biomedical research. His work at IR Sant Pau contributes to the Institute's research programs in oncology and precision medicine, which aim to deepen understanding of disease mechanisms and advance new diagnostic and therapeutic strategies.